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ABSTRACT 
Hormesis encompasses the notion that low levels of stress stimulate or upregulate 16 
existing cellular and molecular pathways that improve the capacity of cells and organisms to 17 
withstand greater stress. This notion underlies much of what we know about how exercise 18 
conditions the body and induces long-term adaptations. During exercise, the body is 19 
exposed to various forms of stress, including thermal, metabolic, hypoxic, oxidative, and 20 
mechanical stress. These stressors activate biochemical messengers, which in turn activate 21 
various signaling pathways that regulate gene expression and adaptive responses. 22 
Historically, antioxidant supplements, nonsteroidal anti-inflammatory drugs, and 23 
cryotherapy have been favored to attenuate or counteract exercise-induced oxidative stress 24 
and inflammation. However, reactive oxygen species and inflammatory mediators are key 25 
signaling molecules in muscle, and such strategies may mitigate adaptations to exercise. 26 
Conversely, withholding dietary carbohydrate and restricting muscle blood flow during 27 
exercise may augment adaptations to exercise. In this review article, we combine, integrate, 28 
and apply knowledge about the fundamental mechanisms of exercise adaptation. We also 29 
critically evaluate the rationale for using interventions that target these mechanisms under 30 
the overarching concept of hormesis. There is currently insufficient evidence to establish 31 
whether these treatments exert dose-dependent effects on muscle adaptation. However, 32 
there appears to be some dissociation between the biochemical/molecular effects and 33 
functional/performance outcomes of some of these treatments. Although several of these 34 
treatments influence common kinases, transcription factors and proteins, it remains to be 35 
determined if these interventions complement or negate each other, and whether such 36 
effects are strong enough to influence adaptations to exercise. 37 
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INTRODUCTION 40 
Hormesis refers to ‘a process in which a low dose of a chemical agent or environmental 41 
factor that is damaging at high doses induces an adaptive beneficial effect on the cell or 42 
organism’ (127). The concept of hormesis first originated in the 16th century from the 43 
musings of the Swiss physician and alchemist Paracelcus, who proposed that, “Solely the 44 
dose determines that a thing is not a poison” (15). The term ‘hormesis’ itself was first coined 45 
in 1943 by Southam and Ehrlich to explain their observation that a natural antibiotic in cedar 46 
wood inhibited the growth of wood-decaying fungi but had the opposite effect at low doses 47 
(204). Subsequently, the pioneering endocrinologist Hans Selye applied this notion to 48 
understanding how biological systems respond to and tolerate environmental stress (194).  49 
Hormesis encompasses the fundamental concepts of ‘conditioning’ and ‘adaptation’. The 50 
concept of conditioning was first recognized following observations that repeated, brief 51 
hypoxic exposure markedly reduced damage to the heart during subsequent myocardial 52 
infarction (141). We now accept that exposure to an agent conditions the system to respond 53 
in some manner (22). The concept of adaptation was originally recognized following 54 
experiments demonstrating that constant exposure of Escherichia coli to mutagens allowed 55 
each bacterium to handle mutagens more efficiently and to develop resistance to 56 
mutagenesis (184). Conditioning and adaptation are closely related, are considered to be 57 
synonymous, and are often used interchangeably. In essence, conditioning/adaptation 58 
captures the notion that low levels of stress stimulate or upregulate existing cellular and 59 
molecular pathways that improve the capacity of cells and organisms to withstand greater 60 
stress (22).  61 
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The notion of hormesis underlies much of what we know about how exercise conditions 62 
the body and induces long-term adaptation (32). However, hormesis was explicitly 63 
introduced into the lexicon of exercise physiology only relatively recently (175). On a gross 64 
population level, the dose−response nature of hormesis most likely explains why moderate 65 
levels of physical activity reduce the risk of illness and mortality, whereas excessive physical 66 
activity increases such risks (5, 103, 147). 67 
During exercise, the body is exposed to various homeostatic perturbations, including 68 
thermal, metabolic, hypoxic, oxidative, and mechanical stress. These perturbations 69 
stimulate the release of biochemical messengers such as reactive oxygen and nitrogen 70 
species (RONS), Ca2+, growth factors, cytokines, and eicosanoids. These messengers then 71 
activate signaling pathways including (but not limited to) various protein kinases, 72 
phosphatases, and deacetylases, which in turn regulate the molecular machinery controlling 73 
gene expression that elicits the appropriate adaptive responses (40). Through these 74 
signaling pathways, acute production of RONS and inflammatory mediators can ultimately 75 
promote adaptations in skeletal muscle such as mitochondrial biogenesis and 76 
remodeling/hypertrophy (53, 124, 125, 169, 197). Conversely, prolonged production of 77 
RONS and inflammatory mediators can activate proteolytic pathways, impede protein 78 
synthesis, and overwhelm endogenous defense mechanisms, which cause adverse effects 79 
such as muscle atrophy/weakness (37, 56, 62, 106, 203, 206). This dichotomy between the 80 
acute and chronic effects of certain physiological stimuli is important to consider within the 81 
context of hormesis in skeletal muscle. 82 
Historically, the perception that exercise-induced oxidative stress and inflammation 83 
cause muscle fatigue and damage has provoked widespread interest in countermeasures 84 
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such as antioxidant supplements, NSAIDs, and cryotherapy (31, 236). However, advances in 85 
our understanding of the role of RONS and inflammatory mediators in muscle adaptations 86 
to exercise have generated debate about whether these strategies are actually beneficial—87 
at least in young healthy people (74, 162, 190). Antioxidant supplements and NSAIDs may 88 
help to preserve or enhance muscle adaptations to exercise in older individuals with 89 
impaired antioxidant defense systems or chronic low-grade inflammation (120, 228). By 90 
contrast, in young people these interventions can attenuate exercise-induced increases in 91 
insulin sensitivity (177) and muscle protein synthesis (229). The advantages or 92 
disadvantages of these interventions may therefore vary between different exercising 93 
populations. At the other end of the hormesis continuum, interest has also emerged in the 94 
potential benefits of applying stress to skeletal muscle before, during, or after exercise to 95 
stimulate greater adaptation. This stress can be applied by restricting carbohydrate intake, 96 
occluding local blood supply using low-intensity isometric or eccentric contractions 97 
(mechanical ‘preloading’), or passively heating muscle. 98 
Considering the increasing attention on strategies to enhance exercise performance and 99 
assist recovery, it is timely to debate the scientific rationale for using interventions such as 100 
cryotherapy, antioxidant supplements, NSAIDs, mechanical preloading, dietary carbohydrate 101 
restriction, heat stress, and blood flow restriction to modulate adaptations to exercise. The 102 
purpose of this review is to combine, integrate, and apply knowledge about how these 103 
interventions influence skeletal muscle adaptations to exercise under the overarching 104 
concept of hormesis. 105 
 106 
INTERVENTIONS THAT ENHANCE EXERCISE-INDUCED HORMESIS 107 
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Restricting Dietary Carbohydrate Intake 108 
Modulating skeletal muscle glycogen content by restricting dietary carbohydrate intake 109 
between exercise sessions is a relatively recent strategy to enhance exercise-induced 110 
hormesis. Glycogen is an important substrate for oxidative phosphorylation in skeletal 111 
muscle, and low muscle glycogen content is a key determinant of muscle fatigue (11, 94, 112 
205). Accordingly, maximizing muscle glycogen content by carbohydrate loading before 113 
exercise and delaying the rate at which glycogen content is depleted (by ingesting 114 
carbohydrate during exercise) are common practices for athletes (21). Recent studies have 115 
used various diet and/or exercise protocols to manipulate muscle glycogen content before 116 
exercise sessions to determine whether changes in glycogen availability influence adaptive 117 
responses [for review see (8, 69)]. There is growing evidence of beneficial effects on 118 
metabolic and mitochondrial adaptations when exercising with low compared with normal 119 
muscle glycogen content. This section briefly examines the putative mechanistic influence of 120 
low muscle glycogen content and any potential for biphasic responses that support the 121 
hormetic model of adaptation. 122 
Training with low muscle glycogen content promotes metabolic adaptation. A primary 123 
concept within the paradigm of nutrient–training interactions in skeletal muscle is that 124 
substrate availability mediates the cellular response to contractile activity (32). However, 125 
such a paradigm oversimplifies the complexity of how substrate availability modulates 126 
adaptation. Hansen et al (65) first examined whether repeated bouts of exercise begun with 127 
low muscle glycogen content induces greater metabolic stress and disruption to 128 
homeostasis in skeletal muscle. They found that resting muscle glycogen content and citrate 129 
synthase activity were higher in subjects who started half of their training sessions with low 130 
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glycogen versus those who always started training with normal glycogen. They concluded 131 
that this was because glycogen depletion caused by the first session dictated that the 132 
second session began with reduced muscle glycogen content. Although differences in the 133 
distribution of the training stimulus may have influenced these findings, there seems little 134 
doubt that the key factor promoting the adaptive response was training ‘low’.  135 
The metabolic flexibility of healthy skeletal muscle permits shifts in substrate oxidation 136 
based on the availability of carbohydrates and fats [for review see (205)]. Consequently, 137 
imposing the need for greater use of fat as a fuel likely explains much of the augmented 138 
adaptation to exercise with low initial muscle glycogen content. The demand for ATP supply 139 
during prolonged moderate- to high-intensity exercise is likely to also increase the 140 
magnitude of the adaptive signal under low-glycogen conditions. In this regard, the 141 
adenosine monophosphate activated protein kinase (AMPK) may be a focal point for 142 
regulating the cellular response to exercise with low initial muscle glycogen content, given 143 
its role as an energy sensor (66, 67). AMPK contains a glycogen-binding domain on one of its 144 
three subunits that causes it to colocalize with glycogen (66, 67, 128). AMPK also regulates 145 
the activity of several signaling pathways including those that promote glucose transport, 146 
fatty acid uptake, and mitochondrial biogenesis (66). The few studies that have quantified 147 
AMPK phosphorylation or activity after exercise begun with low- compared with 148 
normal/high-glycogen content have shown that the greater AMPK response in skeletal 149 
muscle following exercise is associated with lower preexercise glycogen content (242, 249).  150 
Several other putative mediators of skeletal muscle adaptations to endurance exercise 151 
are enhanced after exercise with low initial muscle glycogen content. The phosphorylation 152 
status and mRNA abundance of important regulators of mitochondrial biogenesis (e.g., 153 
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tumor suppressor p53 and peroxisome proliferator-activated receptor coactivator [PGC-1α]) 154 
are more responsive to exercise with low compared with high initial muscle glycogen (9, 155 
172). Similarly, mitochondrial enzyme activity increases after extended training periods 156 
during which exercise is repeatedly begun with low muscle glycogen content (65, 140, 250). 157 
Exercising with an initially low glycogen content also induces favorable metabolic responses, 158 
including greater oxidation of triacylglycerol and net uptake of glucose and fatty acids into 159 
skeletal muscle (75, 242, 250). Peroxisome proliferator-activated receptor δ expression 160 
increases in skeletal muscle after acute and chronic exercise (161), and likely plays an 161 
important function in alterations in muscle substrate metabolism following exercise training 162 
(17). Collectively, these findings suggest that manipulating carbohydrate availability before 163 
and/or during exercise stimulates several of the molecular and metabolic responses that 164 
promote adaptations to training. 165 
Adverse responses to low glycogen content. Low glycogen availability limits its use for 166 
oxidative phosphorylation and may impair excitation–contraction coupling in muscle during 167 
exercise. Specifically, the reduction in Ca2+ release from the sarcoplasmic reticulum (SR) that 168 
accompanies muscle fatigue is associated with depletion of intramyofibrillar glycogen 169 
content (144, 256). In support of this in situ evidence, exercise studies have shown that 170 
depletion of muscle glycogen decreases Ca2+ release from the SR (50, 255). Importantly, SR 171 
Ca2+ release remains suppressed when carbohydrate intake is restricted in the early (4 h) 172 
postexercise recovery period. By contrast, resynthesis of muscle glycogen returns SR Ca2+ 173 
release rates to the preexercise levels (50). Together with the potential to promote shifts 174 
toward greater fat oxidation and inferior rates of carbohydrate oxidation, these responses 175 
could explain, at least in part, why acute exercise intensity is lower and endurance 176 
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performance following chronic training does not improve when using the ‘train low’ 177 
paradigm  (75, 140, 250). 178 
The increase in metabolic stress in skeletal muscle during exercise starting with low 179 
glycogen content may also modulate protein turnover. In principle, higher AMPK activity 180 
(resulting from low muscle glycogen content) could attenuate muscle protein synthesis by 181 
inhibiting translation/elongation. Increased metabolic stress associated with low muscle 182 
glycogen content may also exacerbate protein degradation (66, 72). Camera et al (23) 183 
demonstrated that starting a bout of resistance exercise with low muscle glycogen content 184 
neither promoted nor inhibited the myofibrillar protein synthesis. However, others have 185 
reported that starting exercise with low muscle glycogen content increases the rates of 186 
leucine oxidation and muscle protein degradation (13, 72). More research is needed to 187 
determine the effects of training with low muscle glycogen content on protein turnover—188 
particularly during recovery between training sessions. Nevertheless, it is possible that 189 
exercise starting with low compared with high muscle glycogen content may increase 190 
muscle protein degradation. 191 
Given the potential for conflicting beneficial and detrimental effects of training starting 192 
with suboptimal glycogen content on skeletal muscle adaptations, a key question is: how 193 
low should one go? If a biphasic response is dose dependent, one challenge is to titrate the 194 
threshold for muscle glycogen content that might enhance the metabolic adaptations 195 
without causing complications associated with fatigue or changes in the net protein balance 196 
(Table 1). Perhaps the more pertinent question is not ‘how low’, but for ‘how long’ or ‘how 197 
often’. Although acute restriction of dietary carbohydrate provides a positive stimulus for 198 
metabolic adaptation, repeated depletion or long-term reduction in muscle glycogen 199 
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content may lead to overtraining (4). Therefore, the benefits of restricting carbohydrate 200 
during exercise or training with low initial muscle glycogen content must be balanced 201 
against the risk of fatigue. 202 
 203 
Blood Flow-Restricted Exercise 204 
In addition to nutritional interventions, it is also possible to enhance exercise-induced 205 
hormesis through physical interventions. One such example is applying a pressure cuff to 206 
the proximal regions of a limb during exercise. This practice first originated in Japan and was 207 
initially termed ‘Kaatsu’ training, which means ‘adding pressure’ (187). The first research 208 
published in English was a study by Shinohara et al (200), in which the combination of 209 
moderate resistance (40% of maximum voluntary contraction) and tourniquet ischemia 210 
resulted in a significant increase in strength (in contrast to no change in strength in the leg 211 
that exercised without ischemia). This training method is now more frequently referred to 212 
as ‘blood flow-restricted exercise’ (108). The basic physiological premise behind blood flow-213 
restricted exercise is that it reduces blood flow and occludes the venous return from the 214 
limb (blood pooling). This combination of stimuli increases tissue hypoxia and the 215 
accumulation of metabolites, and thereby increases muscular stress during low-load 216 
resistance exercise (209-211). Blood flow-restricted exercise induces muscle hypertrophy 217 
and increases in muscle strength in the same range as traditional heavy-load strength 218 
training. Importantly, blood flow-restricted exercise induces effects that are absent (or 219 
minor) when low-load exercise is performed without blood flow restriction (108, 114). 220 
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Blood flow restriction results in several local and systemic responses that might 221 
contribute to the enhanced hypertrophic stimulus when combined with low-load resistance 222 
exercise [20−30% of 1 repetition maximum (RM)] (113, 240). In addition to metabolite 223 
accumulation, the suggested mechanisms include increased recruitment of motor units 224 
(rapid development of fatigue) (240), greater growth hormone secretion (215) and oxidative 225 
stress (240), and muscle swelling (blood pooling) (110). Some of the mechanisms are 226 
directly related, because metabolic accumulation causes rapid onset of fatigue (which 227 
increases motor unit recruitment) and increases growth hormone secretion (215, 240). 228 
Because it is difficult to separate these mechanisms, it remains unknown which of these 229 
factors are most important. Nevertheless, combining blood flow restriction with low-load 230 
resistance exercise increases the rate of muscle protein synthesis by activating similar 231 
pathways to those activated after heavy-load strength training (e.g., mammalian target of 232 
rapamycin [mTOR] signaling and MAPKs) (45, 47, 60, 239). Furthermore, low-load blood 233 
flow-restricted exercise seems to induce a rapid and marked activation of satellite cells 234 
(239). Interestingly, this satellite cell activation appears to exceed that which occurs after 235 
traditional heavy-load strength training (145). Satellite cell activation induced by blood flow-236 
restricted exercise is accompanied by an increase in the number of myonuclei, which may 237 
explain some of the muscle hypertrophy in response to blood flow-restricted exercise (18). 238 
The 30−40% increase in cross-sectional area of both type I and II fibers after only seven 239 
sessions of low-load, blood flow-restricted exercise supports the hypertrophic potential of 240 
this method (145). Others have also reported rapid hypertrophy in response to high-241 
frequency (2×/day), low-load, blood flow-restricted exercise over 1−3 weeks (1, 3). 242 
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High-frequency, low-load blood flow-restricted exercise is generally a safe and effective 243 
training regimen because the low load induces less mechanical stress on muscle fibers than 244 
heavy-load strength training. In addition to the benefits described above, some studies also 245 
report no (or only minor) muscle damage and fast recovery after low-load, blood flow-246 
restricted exercise (107, 112). However, the ischemia induced by blood flow restriction 247 
might cause some muscle damage and prolonged recovery if certain thresholds are passed. 248 
There are isolated reports of severe muscle damage resulting in rhabdomyolysis following 249 
blood flow-restricted exercise (82). Sarcolemmal and myofibrillar disruption and slow 250 
recovery of muscle function have also been reported after blood flow-restricted exercise in 251 
other studies (33, 241). These contrasting findings probably reflect differences in the 252 
training status of the study participants, degree of exhaustion, cuff pressure and size, and 253 
exercise intensity/volume. 254 
Signs of damage, such as sarcolemmal disruption, high blood creatine kinase [CK] 255 
activity, and long-lasting fatigue, and rhabdomyolysis have been reported after the first 256 
session of low-load blood flow-restricted exercise (33, 82, 241), but rapid adaptation 257 
thereafter is likely. Performing a fixed number of repetitions per set (e.g., 15–15–15 or 30–258 
15–15–15) causes little or no muscle damage (2, 111), but performing each set to failure 259 
causes more severe damage (33, 82, 241). The size of the cuff and the occlusion pressure 260 
can vary greatly. It can also be difficult to control arterial blood flow and venous return 261 
accurately (109). Collectively, these factors make it difficult to determine the optimal 262 
guidelines for blood flow restriction in combination with low-load resistance exercise. 263 
Although the stress on the exercising muscle during low-load blood flow-restricted 264 
exercise is not well described, some interesting observations have been reported. In a 265 
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volume-matched protocol, blood flow-restricted exercise increased the acute expression of 266 
heat shock proteins (HSPs) in myofibrillar structures (33). Accumulation of small HSPs in 267 
myofibrillar structures was more abundant in type I fibers, indicating that low-load, blood 268 
flow-restricted exercise stresses type I fibers more than type II fibers, which contrasts with 269 
heavy-load strength training (43). This finding suggests that the combination of low-load 270 
resistance exercise and blood flow restriction preferentially stresses type I fibers. Provided 271 
that the stress remains within the optimal range, over the long term, such exercise also 272 
increases the hypertrophy of type I fibers. Importantly, in accordance with the hormesis 273 
theory, the dose is essential because excessive pressure and/or exercise volume/intensity 274 
may cause severe muscle damage, especially at the initiation of blood flow-restricted 275 
exercise. 276 
In summary, applying a pressure cuff to restrict blood flow to an exercising limb—and 277 
thereby blocking venous return—increases the stress to the skeletal muscle during exercise. 278 
Blood flow restriction augments the effect of low-load resistance exercise on muscle 279 
hypertrophy. An important theme that arises from our evaluation is that blood flow 280 
restriction seems to shift muscular stress toward a more optimal range than that achieved 281 
with low-load exercise performed in isolation. However, the large variation in the 282 
application of blood flow restriction and exercise protocols makes it difficult to suggest an 283 
optimal protocol for low-load blood flow-restricted exercise at the present time. Acute 284 
blood flow restriction during exercise induces metabolic/hypoxic stress that ultimately leads 285 
to muscle hypertrophy. However, if used on a regular basis without sufficient recovery, 286 
blood flow-restricted exercise could induce a chronic cycle of muscle degradation and 287 
repair, which may impede rather than improve adaptations to training. 288 
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 289 
Application of Heat to Muscle 290 
 Applying heat to muscle is another physical intervention that may enhance exercise-291 
induced hormesis. Historically, heat has been used to treat severe muscle injuries (104), 292 
although it may also improve recovery from less severe exercise-induced muscle damage. 293 
The fundamental benefit of using heat in the management of muscle injuries involves an 294 
increase in local blood flow (191, 245), which likely serves to improve the supply of oxygen 295 
and nutrients to assist tissue repair (52). The alternative concept of using heat to 296 
‘precondition’ cells and tissues against other forms of stress was recognized around 20 years 297 
ago. It was termed ‘cross-tolerance’ (248), and is a classic example of hormesis. It has 298 
stimulated interest in the potential for heat preconditioning to protect myocardial tissue 299 
against infarction (121) and skeletal muscle against atrophy (142). An increasing number of 300 
studies have investigated the effects of heat application before or after various forms of 301 
muscle injury on muscle regeneration and the associated mechanisms (Table 2). 302 
Heat preconditioning. There is convincing evidence that heat stress assists recovery from 303 
muscle injury. Application of heat (41°C) before in vitro muscle contraction augments 304 
protein synthesis and expression of HSP72 in muscle cells (55, 247). In rats, heat 305 
preconditioning 12−48 h before muscle injury increases muscle fiber cross-sectional area 306 
and number of centrally nucleated fibers (96). This form of treatment also minimizes fiber 307 
degeneration (199) and mitochondrial damage (48) after injury, and assists in maintaining 308 
muscle mass during reloading after immobilization in rats (199).  309 
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Various mechanisms have been identified to explain these effects including: (i) an 310 
increase in phosphocreatine content, which is associated with less necrosis (48, 181); (ii) 311 
maintenance of reactive oxygen species-scavenging activity (199); (iii) increased expression 312 
of myosin heavy chain protein and HSPs (193, 223); and (iv) more Pax7+ satellite cells (96) in 313 
regenerating muscle. Heat preconditioning also reduces oxidative damage to muscle protein 314 
(193) and infiltration of mononuclear inflammatory cells (96, 199, 223) after muscle injury in 315 
rats. In addition to these studies on muscle injury, heat preconditioning increases the 316 
activity of PGC-1α and AMPK in C2C12 myotubes (84) and prevents muscle atrophy in 317 
response to immobilization (192) and hindlimb unloading in rats (142).  318 
Research on the effects of heat preconditioning on recovery from exercise-induced 319 
muscle damage in humans has produced more variable findings. Some work indicates that 320 
heat stress before eccentric exercise can reduce muscle fatigue (77), promote faster 321 
recovery of strength and range of motion, and alleviate muscle soreness (149, 183). Heat 322 
preconditioning also increases the activation of Akt, mTOR, ribosomal protein S6, and 323 
eukaryotic translation initiation factor 4E-binding protein 1 (EIF4E-BP1) after resistance 324 
exercise (90). In contrast with these studies, others have reported no benefits of heat 325 
preconditioning on the recovery of strength, range of motion, edema, or soreness after 326 
eccentric exercise (86, 151). 327 
Heat stress after muscle injury/exercise. Various animal studies have reported that applying 328 
heat after muscle injury increases muscle fiber cross-sectional area and number of centrally 329 
nucleated fibers (68, 71, 96, 154, 216). Consistent with the effects of heat preconditioning, 330 
these benefits of therapeutic heat treatment are conferred by upregulation of HSPs in 331 
muscle (71, 154). Heat application after muscle injury in rats also induces more rapid 332 
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macrophage infiltration (216); expression of IGF-1 (216), MyoD, and myogenin (68), 333 
calcineurin (154); and activity of Pax7+, MyoD+, and M-cadherin+ satellite cells (96, 154, 216). 334 
Conversely, applying heat to muscle following injury reduces myeloperoxidase activity, 335 
production of RONS, lipid peroxidation, and fibrosis in rats (25, 71, 216).  336 
Relatively little is known about how applying heat to muscle after exercise influences 337 
acute recovery of muscle function. One study reported that, compared with passive 338 
recovery, hot water immersion (38°C for 14 min) after eccentric exercise improved the 339 
recovery of strength, but not that of muscle power, swelling, or soreness (231). The same 340 
group reported that hot water immersion did not help to maintain sprint or time trial 341 
performance over 5 days of high-intensity cycling (230).  342 
No studies have investigated the effects of regular heat application on chronic muscle 343 
adaptations to training. However, evidence from a recent study on rats suggests some 344 
potential benefits of heat to enhance training adaptations. In this study, rats that were 345 
placed in a heat chamber at 41°C for 30 min immediately after treadmill running showed 346 
greater chronic increases in the activity of citrate synthase and 3-hydroxyacyl CoA 347 
dehydrogenase, and mitochondrial protein content in skeletal muscle after 3 weeks of 348 
training (5 days/week) (217). 349 
The transcription factor heat shock factor-1 (HSF-1) and it downstream effectors, HSPs, 350 
are most likely central to the benefits of heat stress for healing of muscle injuries, as 351 
demonstrated in animal studies outline below. HSF-1 and HSPs may assist muscle 352 
regeneration by protecting muscle cells against oxidative damage, apoptosis, and ATP 353 
depletion (16, 87-89, 118). HSPs may also promote repair of muscle tissue by activating the 354 
signaling pathways involved in protein synthesis (e.g., Akt, p70S6 kinase, and ERK) (61) and 355 
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by regulating the activity of enzymes and transcription factors that can cause degeneration 356 
and/or atrophy of muscle fibers (38, 49, 105, 195). Importantly, without HSF-1 and HSP70, 357 
macrophage infiltration is delayed, and the expression of proinflammatory cytokines is 358 
dysregulated in regenerating muscle tissue (98, 148, 196). Heat stress may also increase 359 
muscle hypertrophy independently of HSPs by stimulating the expression of IGF-1, 360 
myogenin, and Pax7 (166). Increased expression of IGF-1 in response to heat stress likely 361 
complements the effects HSPs by orchestrating more efficient resolution of inflammation 362 
following muscle injury (160). 363 
This review is the first summary and critical evaluation of the effects of applying heat to 364 
muscle with the goal of promoting repair and growth of muscle. Acute heat stress increases 365 
the activities of HSPs, satellite cells, PGC-1α, and AMPK, whereas it reduces oxidative 366 
damage in muscle after exercise/injury. Over the long term, these responses may augment 367 
training adaptations. Although the application of heat stress before or after muscle injury 368 
has shown promising results in muscle cell culture and animal studies, more work is 369 
required to establish whether these same benefits occur in humans. 370 
 371 
Mechanical Preloading 372 
A single bout of eccentric muscle contractions confers protection against subsequent 373 
bouts of muscle-damaging exercise. This response is referred to as the ‘repeated-bout 374 
effect’, and may last between 6 and 9 months (150). The repeated bout effect can also occur 375 
in the non-exercising contralateral limb, although the effect in the contralateral limb is 376 
smaller than that in the ipsilateral limb (73). 377 
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Recent interest has focused on trying to determine the minimum stimulus required to 378 
elicit protection against muscle damage, which is typically characterized by prolonged 379 
decreases (>1 d) in muscle function and delayed-onset muscle soreness (DOMS). Herein, we 380 
refer to this approach to strength training and conditioning as ‘mechanical preloading’. 381 
Although this is a relatively new concept, it is a classic example of exercise-induced 382 
hormesis, whereby mild mechanical preloading of skeletal muscle induces positive 383 
adaptations. The first evidence for the benefits of mechanical preloading came from a study 384 
demonstrating that low-intensity isometric contractions (performed at 10% of maximal 385 
voluntary contraction strength) improved the recovery of strength by 50−60% and reduced 386 
peak muscle soreness by 30% after subsequent eccentric exercise performed 2 days later 387 
(101). These protective effects of mechanical pre-loading seem to last between 1 and 2 388 
weeks (26). 389 
Mode and intensity of contraction. The preloading effect does not appear to be specific to 390 
the type of muscle contraction. Preloading with as few as two maximum voluntary isometric 391 
contractions at a long muscle length (20° flexion) is sufficient to attenuate the loss of 392 
strength and range of motion, DOMS, and swelling after eccentric exercise performed 2 393 
days later (27). As evidence of a dose response, 10 maximal voluntary isometric contractions 394 
at the same muscle length conferred even greater protective effects (27). The protective 395 
effect conferred by two maximal isometric contractions appears to last only a maximum of 1 396 
week (28). Compared with low-intensity eccentric contractions (10% maximum strength), 397 
maximal isometric contractions performed at 20° flexion confer a greater degree of 398 
protection against subsequent muscle damage (30). However, the protective effect of 399 
maximal isometric contractions is less than that resulting from maximal eccentric 400 
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contractions (30). Four bouts of moderate-intensity eccentric exercise comprising eccentric 401 
contractions at 40% of maximal voluntary isometric contraction, performed every 2 weeks, 402 
confers a similar protective effect to one bout of maximal eccentric exercise (29). This 403 
finding suggests that repeating submaximal eccentric exercise provides the same protection 404 
as one bout of maximal eccentric exercise against the subsequent maximal eccentric 405 
exercise. It remains to be determined whether regular lighter intensity eccentric 406 
contractions (e.g., 10%) or maximal isometric contractions at a long muscle length increase 407 
long-term muscle adaptations. 408 
Integration of the findings of the small number of studies in this area shows that a few 409 
eccentric contractions at low intensity or a few maximal isometric contractions at long 410 
muscle length confer significant protection against subsequent muscle damage. In addition 411 
to contracting muscles, this effect most likely also occurs in non-exercising muscles of the 412 
contralateral limb. The mechanisms underpinning the effects of mechanical preloading on 413 
muscle adaptation are currently unknown. Adaptation to maximal eccentric contractions 414 
has been attributed to various factors, including neural changes (e.g., increased motor unit 415 
recruitment/synchronization), remodeling of connective tissue, removal of weak fibers, and 416 
longitudinal addition of sarcomeres (131). Light-intensity eccentric contractions and 417 
isometric contractions do not cause any loss of strength or range of motion, muscle 418 
swelling, or DOMS (27, 101). Without causing frank muscle damage, these types of 419 
contractions may precondition skeletal muscle through other mechanisms. Such 420 
mechanisms could include physical changes to the fascia and endomysium or metabolic 421 
alterations in ATP availability, intracellular [Ca2+], mitochondrial Ca2+ uptake, RONS signaling, 422 
21 
 
or proteolytic activity. Further research is warranted to examine these putative mechanisms 423 
in greater detail.  424 
Because acute muscle damage resulting from mechanical preloading is minimal, it seems 425 
unlikely that long-term use of this form of preconditioning will increase the risk of 426 
maladaptation to training. However, the protective effect of mechanical preloading may 427 
diminish if it is used repeatedly because muscle probably adapts to such mechanical 428 
stimulation. Consistent with this premise, any benefits of mechanical preloading are 429 
probably relatively minor for resistance-trained individuals who regularly perform 430 
submaximal eccentric contractions and maximal isometric contractions in their training 431 
routines. Future studies in this area could investigate whether skeletal muscle 432 
remodeling/hypertrophy is still induced effectively if no muscle damage is induced 433 
throughout training. 434 
 435 
INTERVENTIONS THAT DAMPEN EXERCISE-INDUCED HORMESIS 436 
Antioxidant Supplementation 437 
The notion of hormesis has been studied extensively in the context of oxidative stress 438 
and its opposing roles in skeletal muscle pathologies. It has also been examined as a 439 
potential stimulus for redox adaptations in skeletal muscle following endurance training. For 440 
the purposes of this review, the term ‘oxidative stress’ is defined as an imbalance between 441 
oxidants and antioxidants in favor of the oxidants, leading to a disruption of redox signaling 442 
and control and/or molecular damage (171). Davies et al (34) were the first to report that 443 
submaximal exercise to exhaustion increased the production of free radicals in rodent 444 
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skeletal muscle. Other more recent studies have also shown that exhaustive endurance 445 
exercise increases oxidative stress in rat skeletal muscle (10, 91, 235). Although these 446 
studies provide vital proof of principle, understanding precisely how RONS regulate skeletal 447 
muscle adaptations to endurance training is difficult—mainly because few training programs 448 
regularly push individuals to exhaustion. Nevertheless, moderate- to high-intensity 449 
endurance exercise (70−85% of maximal oxygen uptake) is sufficient to increase oxidative 450 
stress in rat skeletal muscle, as measured by changes in GSSG levels (237, 238, 254). 451 
Moderate-intensity endurance cycling exercise is also sufficient to increase lipid 452 
peroxidation, as measured by F2-isoprostane content in skeletal muscle of humans (92). 453 
Bailey et al (7) provided the first direct evidence in humans that exercise in the form of 454 
maximal, single-leg knee extension increases intramuscular free radical accumulation. 455 
Oxidative stress and mitochondrial biogenesis in skeletal muscle. Redox-sensitive kinases 456 
activated during muscle contraction include AMPK, activating transcription factor-2 (ATF-2), 457 
NFκB, and the MAP kinases p38 MAPK, JNK, and ERK (also called p44/42 MAPK) (53, 79, 185, 458 
238). These kinases are all implicated in the regulation of mitochondrial biogenesis (83, 459 
243)—at least partly through the transcriptional coactivator PGC-1α, which is a key 460 
regulator of mitochondrial biogenesis (173, 244). Although RONS were first proposed to 461 
regulate exercise-induced mitochondrial biogenesis over 30 years ago (34), it was Silveira et 462 
al who first published clear evidence linking RONS with the regulation of contraction-463 
induced mitochondrial biogenesis in rat muscle cells (201). Importantly, this group 464 
demonstrated that antioxidants attenuated the increase in RONS production and PGC-1α 465 
mRNA expression (201). Hood et al (79) have since provided more direct evidence for the 466 
role of RONS (and antioxidants) in regulating the expression of AMPK and PGC-1α in skeletal 467 
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muscle cells. Other proteins such as upstream stimulatory factor 1 also play an important 468 
role in regulating PGC-1α activity in skeletal muscle (80). 469 
Antioxidants and mitochondrial biogenesis. Research on the effects of antioxidants on 470 
mitochondrial biogenesis has used vitamins C and E (alone or in combination), coenzyme 471 
Q10, N-acetylcysteine, β-carotene and α-lipoic acid in rats (54, 70, 208, 234) and humans 472 
(157, 163, 177, 251). Because of the large number of individual antioxidant supplements, a 473 
comprehensive examination of each antioxidant is beyond the scope of the current review 474 
(for review, see (120). This review is limited to evaluation of hormesis specifically in relation 475 
to vitamins C and E because they are two of the most common antioxidant supplements 476 
used alone or in combination by the general population (180) and in research (54, 70, 157, 477 
177, 208, 234, 251). Given the role of RONS in stimulating mitochondrial biogenesis in 478 
skeletal muscle (79, 201), many studies have investigated whether antioxidant supplements 479 
prevent adaptations to endurance training. Some training studies have found that vitamin C 480 
and/or vitamin E attenuates markers of mitochondrial biogenesis in muscle after training in 481 
rats (54, 234) and humans (157, 177). By contrast, other studies have found no significant 482 
effects of antioxidant supplements on markers of mitochondrial biogenesis (70, 208, 251, 483 
253). 484 
Despite this evidence for a reduction in cellular adaptations to endurance training with 485 
antioxidants (54, 157, 177, 234), no research has reported any change in maximum oxygen 486 
uptake or exercise performance—at least in humans (157, 178, 251). Animal studies have 487 
demonstrated that vitamin C supplementation reduces the improvements in exercise 488 
performance after 6 weeks of exercise training (54, 126). Differences in the metabolism of 489 
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vitamin C in skeletal muscle between humans and rats may partially account for these 490 
differences. 491 
Despite strong evidence that endurance exercise increases oxidative stress in human 492 
skeletal muscle (7, 92, 254), it remains uncertain whether vitamin C and/or E 493 
supplementation inhibits oxidative stress in human skeletal muscle during exercise. One 494 
reason for this uncertainty is the lack of suitable markers of RONS production and oxidative 495 
stress in skeletal muscle during exercise. Some studies have used plasma or blood to assess 496 
oxidative stress (70, 157). However, this is problematic because the degree of systemic 497 
oxidative stress in plasma/blood may not reflect the extent of local oxidative stress in 498 
skeletal muscle (235). Furthermore, other markers of oxidative stress (e.g., thiobarbituric 499 
acid reactive substances (TBARS) or malondialdehyde) may not be specific or sensitive to 500 
antioxidant supplementation (182, 252). 501 
In addition to discrepancies between the effects of antioxidants in animals compared 502 
with humans, there is also some disparity between the acute and chronic effects of 503 
antioxidants. For example, several acute exercise studies show that inhibiting RONS derived 504 
from xanthine oxidase with the xanthine oxidase inhibitor, allopurinol, inhibits the exercise-505 
induced phosphorylation of redox-sensitive kinases such as p38 MAPK and ERK, which 506 
regulate mitochondrial biogenesis in rats (53, 91, 238). However, long-term treatment with 507 
allopurinol does not prevent the increases in skeletal muscle mitochondrial proteins or 508 
antioxidant enzymes following endurance training in rats (238). One possible reason for this 509 
disparity is that stimuli other than RONS, such as cytosolic Ca2+ (130, 155), AMP (130), and 510 
possibly NAD (51) also regulate mitochondrial biogenesis in skeletal muscle. Thus, although 511 
antioxidant supplements can inhibit RONS production in skeletal muscle, this may not 512 
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always attenuate mitochondrial biogenesis probably because of redundancies within these 513 
pathways. 514 
Antioxidants and skeletal muscle hypertrophy. There is substantial evidence linking oxidative 515 
stress with muscle atrophy [for review see (170)]. Emerging evidence also implicates 516 
oxidative stress in the regulation of skeletal muscle hypertrophy. A high daily oral dose of 517 
vitamin C attenuates skeletal muscle hypertrophy and oxidative stress normally observed 518 
following mechanical overload of the plantaris (119). Recent findings in rodents 519 
demonstrate that the highly reactive oxidant, peroxynitrite regulates skeletal muscle 520 
hypertrophy induced by overload (81). Peroxynitrite appears to operate by stimulating the 521 
release of intracellular Ca2+, which then activates mTOR to increase protein synthesis (119). 522 
The few human studies to investigate the adaptations to resistance training combined 523 
with antioxidant supplementation have reported variable findings. Two studies showed no 524 
effect of vitamin C and E supplementation on improvements in skeletal muscle strength or 525 
performance (14, 220). However, these studies used resistance training protocols that did 526 
not induce skeletal muscle hypertrophy (14) or did not measure changes in lean muscle 527 
mass (220). Paulsen et al (159) recently found that supplementation with vitamins C and E 528 
attenuated the activities of several kinases involved in hypertrophy signaling, such as p70S6 529 
kinase and the redox-sensitive kinases p38 MAPK and ERK 1/2 in skeletal muscle after 10 530 
weeks of resistance training. In addition, supplementation attenuated bicep curl strength 531 
following 10 weeks of training. By contrast, supplementation did not alter protein synthesis 532 
or muscle hypertrophy following training (159). Thus, some evidence supports blunting of 533 
the cell signaling pathways with antioxidant supplementation following resistance exercise, 534 
although the effects on functional outcomes remain equivocal. More studies are required to 535 
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examine whether RONS regulate hypertrophy following resistance training in human 536 
skeletal muscle and whether antioxidant supplementation influences these adaptations to 537 
resistance exercise. 538 
 In summary, oxidative stress plays an important role in regulating the mitochondrial 539 
content and perhaps contractile protein content of skeletal muscle. Some evidence shows 540 
that supplementation with vitamins C and E can block acute increases in signaling pathways 541 
that control mitochondrial biogenesis and hypertrophy. However, these acute responses do 542 
not consistently translate to less mitochondrial biogenesis or muscle hypertrophy following 543 
chronic exercise training because of the apparent redundancy in skeletal muscle. That is, 544 
exercise training (either endurance or resistance) may induce mitochondrial biogenesis and 545 
hypertrophy despite elevated concentrations of RONS-scavenging antioxidants. The weight 546 
of current evidence suggests that vitamin C and E supplementation may dampen exercise-547 
induced hormesis—at least at the cellular level. However, it remains uncertain whether 548 
these responses influence exercise performance in the long term. Importantly, antioxidant 549 
compounds have widely divergent properties, and this discussion of a specific class of 550 
agents does not rule out the effects of other components on RONS activity/regulation, nor a 551 
role for RONS in exercise-induced adaptation. The requirement for and efficacy of 552 
antioxidant supplements may vary with age and health status. There are conflicting and 553 
unresolved issues surrounding the influence of antioxidant supplementation on adaptations 554 
to training that require further investigation. 555 
 556 
NSAIDs 557 
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Similar to antioxidants, NSAIDs represent another pharmacological intervention that 558 
may attenuate exercise-induced hormesis. NSAIDs are inhibitors of the cyclooxygenase 559 
(COX) pathway that converts free arachidonic acid to PGD2, PGE2, PGF2α, PGI2, and 560 
thromboxane A2 (42, 232). PGs are autocrine/paracrine lipid mediators that propagate the 561 
inflammatory response to tissue injury by increasing blood flow, vascular permeability, and 562 
leukocyte chemotaxis (35). COX has two major isoforms. COX-1 is constitutively expressed, 563 
and COX-2 expression is generally low but is highly inducible in response to injurious stimuli 564 
(57, 139). Classical NSAIDs inhibit both COX-1 and COX-2 to varying degrees (36, 202). 565 
Undesirable side effects associated with disruption of homeostatic COX-1 activity have led 566 
to the development COX-2-specific inhibitors (coxibs) for treating pain and inflammation. 567 
During postexercise recovery, the activities of COX-1 and COX-2 (24) and concentrations of 568 
PGs (20, 93, 225, 227) increase transiently in skeletal muscle. Plasma PG concentrations also 569 
increase after exercise (39, 123, 218). These responses point to important roles for the 570 
COX/PG pathway in exercise adaptation. On the other hand, chronically elevated PG 571 
concentrations are associated with—and may contribute directly to—muscle wasting in 572 
states of chronic inflammation (97). 573 
Effect of NSAIDs on acute muscle responses to exercise. Classical NSAIDs (e.g., ibuprofen and 574 
indomethacin) administered at over-the-counter doses effectively block the acute exercise-575 
induced increase in PG concentration in muscle (20, 135, 227) and plasma (123). Although 576 
not considered a classical NSAID, acetaminophen also appears to inhibit COX activity in 577 
muscle (227). Many studies have investigated the effect of NSAIDs on symptoms of exercise-578 
induced muscle damage, although the literature on the efficacy of NSAIDs for reducing 579 
muscle soreness and/or improving exercise recovery is contradictory. Given that NSAIDs are 580 
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anti-inflammatory, it is surprising that studies to date have failed to observe any effect of 581 
NSAIDs on systemic (95, 167, 222) or intramuscular (158) leukocyte responses to exercise 582 
stress. Paradoxically, short-term NSAID treatment appears to increase plasma cytokine 583 
concentrations (e.g., IL-6 and monocyte chemotactic protein-1) (41, 59, 138, 146) and 584 
muscle COX-2 gene expression (19, 138) after exercise. 585 
Together with a lack of a clear benefit of NSAIDs in reducing exercise-induced pain 586 
and/or the acute inflammatory response in humans, various studies have shown potential 587 
negative effects of NSAIDs in muscle after exercise. Oral ingestion of the nonselective 588 
NSAIDs ibuprofen or acetaminophen blunts the increase in muscle protein synthesis during 589 
postexercise recovery in young men (229). However, this effect was not replicated in a study 590 
of patients with knee osteoarthritis who received ibuprofen (165). Another nonselective 591 
NSAID (indomethacin) blocked the muscle satellite cell response to a 36 km run (117) and 592 
maximal eccentric exercise (137) but did not alter muscle protein synthesis (138). Studies 593 
have shown that COX-2-selective inhibitors do not influence muscle protein synthesis (19) or 594 
satellite cell responses to exercise (158), suggesting that COX-1 rather than COX-2 may be 595 
the primary isoform involved in human muscle responses to exercise.  596 
The underlying mechanisms by which NSAIDs influence muscle adaptive responses to 597 
exercise remain unclear, but several recent studies have provided useful insights. Impaired 598 
satellite cell proliferation following maximal eccentric exercise with local indomethacin 599 
infusion (135) did not alter the expression of growth factors and extracellular matrix-related 600 
genes (138) or HSP (136) in muscle. Oral ibuprofen treatment blocked the normal increase 601 
in serum PG concentration during early postexercise recovery (0−3 h) (123), and suppressed 602 
phosphorylation of components of the ERK and mTOR signaling pathways in muscle (122). 603 
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These data provide the first evidence that PGs contribute to contraction-induced signaling in 604 
human muscle and provide mechanistic support for a potentially detrimental effect of oral 605 
nonselective NSAIDs (122, 125). Interestingly, mass spectrometry profiling of serum samples 606 
collected throughout exercise recovery revealed suppression of both early proinflammatory 607 
and later anti-inflammatory/proresolving lipid mediator circuits in subjects receiving 608 
ibuprofen (123). Thus, NSAIDs may interfere with exercise recovery indirectly by delaying or 609 
preventing timely resolution of the inflammatory response (123, 233). 610 
Chronic effects of NSAIDs on muscle exercise adaptation. Although nonselective NSAIDs may 611 
attenuate acute responses to exercise in humans (122, 123, 137, 138, 227, 229), it remains 612 
unclear whether these responses influence long-term adaptations to exercise. Oral 613 
ibuprofen treatment (400 mg/day) did not influence muscle hypertrophy or strength 614 
following 6 weeks of resistance training of the elbow flexors in young healthy men (99). 615 
However, this dose of ibuprofen was only one-third that used in acute exercise studies (122, 616 
123, 227, 229). By contrast, animal studies clearly show a deleterious effect of NSAID 617 
treatment on long-term muscle regeneration and hypertrophy, and specifically implicate the 618 
COX-2 isoform in this response (100, 124, 152, 198). 619 
In older adult subjects, gains in skeletal muscle size and strength following 12 weeks of 620 
resistance training were greater in response to treatment with ibuprofen (1,200 mg/day) or 621 
acetaminophen (4 g/day) compared with a placebo treatment (224). Another study also 622 
revealed that ibuprofen augmented training-induced gains in muscle strength in elderly 623 
subjects but did not influence muscle mass and tended to reduce satellite cell numbers in 624 
muscle (164). By contrast, a lower dose of acetaminophen (1,000 mg/day) did not alter fat-625 
free-mass or muscle strength in older men after a period of resistance exercise training (85). 626 
30 
 
One mechanism through which NSAIDs may exert positive effects on muscle involves a 627 
reduction in chronic low-grade inflammation that occurs with aging, thereby blocking the 628 
pathway to muscle atrophy. NSAID treatment counteracts skeletal muscle wasting in animal 629 
models of chronic inflammatory disease including cancer cachexia (129, 202, 207), arthritis 630 
(56), and aging (176). Consistent with this hypothesis, older adults who received ibuprofen 631 
throughout 12 weeks of resistance training showed a chronic reduction in the expression of 632 
cytokine genes (e.g., IL-6, IL-10) and muscle ring finger 1 (MuRF-1) (226). 633 
In summary, the COX/PG pathway appears to play an important role in acute exercise 634 
recovery, and NSAIDs inhibit the seemingly beneficial acute muscle adaptive responses to 635 
exercise (e.g., satellite cell proliferation and muscle protein synthesis). On the other hand, 636 
chronic activation of the COX/PG pathway may exert negative effects on muscle mass, and 637 
NSAID treatment may provide an effect countermeasure against such effects. In this review, 638 
we have highlighted an apparent discrepancy between the opposing effects of NSAIDs in 639 
different settings (e.g., acute versus chronic, young versus old subjects). The balance 640 
between PG species with differing bioactivity (e.g. PGF2α versus PGE2) (228) or differences in 641 
the underlying nature of the inflammatory response (acute self-resolving versus chronic 642 
nonresolving) (97, 122) may be important factors that influence the pharmacological actions 643 
of NSAIDs. 644 
 645 
Cryotherapy 646 
Cryotherapy in the form of ice massage and application of crushed ice has long been a 647 
common treatment for soft tissue injuries (132). More recently, other forms of cryotherapy 648 
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such as cold water/ice baths and brief exposure to extreme cold air (−20 to −110°C) in 649 
custom-made cryotherapy chambers have gained popularity as strategies to recover from 650 
exercise. Traditionally, the physiological basis for using cryotherapy has been to relieve pain, 651 
reduce tissue metabolism, and modify vascular responses to minimize edema (213). Acute 652 
responses to primary muscle injury (e.g., necrosis and inflammation) can result in 653 
‘secondary injury’ to healthy cells not damaged through the initial trauma (134). By reducing 654 
the metabolic rate of tissues within and around the injury site, cryotherapy may protect the 655 
healthy bystander cells from the ischemic environment in the immediate period after injury, 656 
thereby reducing the risk of secondary cell injury or death (12). Some evidence from animal 657 
studies support this notion (133, 134, 156, 186). However, the effects of cryotherapy on 658 
muscle inflammation in humans are currently unknown. 659 
Effects of cryotherapy on inflammation and oxidative stress. Studies have focused on how 660 
icing influences inflammation and oxidative stress in muscle following injury (Table 3). 661 
Superfusing rats with cold saline (3−8°C) for 10 min to 6 h after muscle contusion injury 662 
significantly reduced leukocyte rolling and adhesion to venules within damaged muscle for 663 
up to 1 day after injury (102, 188, 189). These effects may be mediated by downregulation 664 
of adhesion molecules on the surface of vessels and leukocytes in response to hypothermia 665 
(63, 78). Immunohistochemical analysis of muscle tissue revealed that this cryotherapy 666 
treatment decreased the number of neutrophils in muscle 1 day after injury (188, 189). In 667 
support of these findings, others have observed that icing after muscle strain injury in rats 668 
substantially reduced neutrophil activation in muscle, as indicated by lower 669 
myeloperoxidase activity 1 day after injury (25). Icing also restricted the production of RONS 670 
and lipid peroxidation at 1, 5, 10 and 15 days after injury in rats (25). Icing preserves the 671 
32 
 
activity of Na+-K+-ATPase and Ca2+-ATPase enzymes and mitochondrial membrane 672 
permeability, and it reduces mitochondrial swelling in muscle 1 day after contusion injury in 673 
rats (174). Because none of these studies assessed muscle regeneration in the weeks 674 
following injury, it is difficult to establish whether restricting neutrophil invasion and 675 
activation through cryotherapy results in better healing of muscle injuries. In principle, a 676 
decrease in neutrophil infiltration into muscle as a result of icing is potentially beneficial 677 
because activated neutrophils can damage skeletal muscle fibers (143, 168). 678 
Effects of cryotherapy on muscle regeneration. Other studies in rats have shown that icing 679 
causes greater fibrosis and impairs muscle regeneration after muscle contusion and crush 680 
injuries. These effects are evident as early as 2 days after injury (76) and persist for up to 4 681 
weeks (214). The potential mechanisms responsible for these effects include delayed 682 
macrophage infiltration and mRNA expression of transforming growth factor-β1 and IGF-1 in 683 
muscle, together with a delay in (or absence of) satellite cell activation (76, 214). Impaired 684 
muscle regeneration in response to icing may be attributed to the following sequence of 685 
events. By restricting neutrophil infiltration, icing may slow the rate of phagocytosis of 686 
necrotic muscle tissue in the first few hours after injury (219). Persistent necrosis may then 687 
delay the entry of macrophages into muscle tissue in the first few days after injury (58). 688 
Finally, by delaying macrophage infiltration, icing may reduce the capacity of these cells to 689 
(a) produce essential growth factors and chemotactic agents (64, 115, 116, 212), and (b) 690 
stimulate satellite cells to proliferate and differentiate (6, 221). The limited evidence that is 691 
currently available therefore suggests that cryotherapy is detrimental for muscle 692 
regeneration following injury. 693 
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Effects of cryotherapy on training adaptations. In addition to this research on acute muscle 694 
injury, a smaller body of research has investigated the effects of regular cryotherapy on 695 
muscle adaptations to exercise training. An early study demonstrated that, in rats regularly 696 
immersed in cold water (4°C) for 5 min after exercise bouts, greater ultrastructural damage 697 
to myofibrils was evident after 5 weeks of exhaustive running and 7 weeks of moderate 698 
running (46). Fu et al proposed that, by masking pain, cold water immersion allowed the 699 
rats to exercise at higher intensities the next day, which unexpectedly resulted in greater 700 
muscle damage (46). Subsequently, several human studies have also reported that regular 701 
cold water immersion after exercise attenuates muscle adaptations to training (44, 153, 702 
179, 246). The mechanisms by which regular cold water immersion dampened training 703 
adaptations in these studies are unknown. Hypothetically, a decrease in muscle blood flow 704 
in response to cold water immersion might reduce angiogenesis and protein synthesis in 705 
muscle during recovery from exercise. In turn, these responses may result in smaller gains in 706 
muscular endurance and strength. 707 
This review is the first critical evaluation of the short- and long-term effects of various 708 
forms of cryotherapy on cellular responses in skeletal muscle. We have also outlined in 709 
detail the putative mechanisms by which cryotherapy influences muscle repair and growth. 710 
When applied acutely after exercise or muscle injury, cryotherapy may help to reduce 711 
muscle soreness and minimize secondary tissue damage. However, by attenuating some key 712 
inflammatory reactions (e.g., macrophage infiltration) in skeletal muscle, cryotherapy may 713 
also block the production and release of important growth factors and the activity of 714 
satellite cells, which are important mediators of muscle repair and adaptation. Therefore, 715 
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although cryotherapy offers some short-term benefits, these are possibly outweighed by 716 
long-term detrimental effects. 717 
 718 
PERSPECTIVES AND FUTURE DIRECTIONS 719 
  This is the first commentary to combine, summarize, and evaluate the efficacy of 720 
various strategies to modulate exercise-induced hormesis. Some of these strategies (e.g., 721 
antioxidant supplementation, treatment with NSAIDs, restriction of dietary carbohydrate 722 
intake) have been the subject of scientific scrutiny and debate. By contrast, other strategies 723 
such as cryotherapy, blood flow restriction, heat stress, and mechanical preloading have 724 
received less critical attention. In this review, we have detailed the conceptual frameworks 725 
for the use of such strategies, have integrated these details with the current knowledge 726 
about the basic biochemical and molecular machinery that regulate muscle adaptations to 727 
exercise, and have applied this information to assess the advantages and disadvantages of 728 
each strategy for modulating exercise-induced hormesis. 729 
Table 4 summarizes the mechanisms of action of treatments that modulate exercise-730 
induced hormesis and describes some of the short- and long-term outcomes of these 731 
treatments. A key finding from this review is that there appears to be some dissociation 732 
between the biochemical/molecular effects and functional/performance outcomes of some 733 
of these treatments (e.g., antioxidants, NSAIDs, restriction of dietary carbohydrate). 734 
Conceivably, other signaling pathways that are less responsive to these treatments (or not 735 
yet defined) may operate independently in the regulation of training adaptations. This 736 
redundancy may promote fine-tuning of adaptive responses to exercise training (40). Few of 737 
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the interventions described in this review have been adequately tested to determine if or 738 
how they exert dose-dependent effects on muscle adaptation. If such dose-dependent 739 
effects do occur, they are likely to be subject to highly complex regulatory mechanisms.  740 
A common feature of hormesis is that exposure to one type of hormetic agent can 741 
protect cells/organisms against more types of stress (127). This concept of ‘cross tolerance’ 742 
may be applied to some of the interventions that we have discussed. Several of the 743 
interventions influence common kinases, transcription factors, and proteins (see Table 4). 744 
For example, AMPK, p38 MAPK, PGC-1α, and HSP expression increases in response to heat 745 
stress, carbohydrate restriction, and blood flow restriction, whereas the expression of most 746 
of these factors decreases following antioxidant supplementation. Similarly, macrophage 747 
infiltration, IGF-1, and Pax7 expression increases in response to heat stress, whereas these 748 
factors are either blocked or activated more slowly after cryotherapy. It remains to be 749 
determined whether these interventions complement or negate each other and whether 750 
such effects are strong enough to alter terminal adaptive processes such as mitochondrial 751 
biogenesis, substrate metabolism, or muscle repair/growth. 752 
 Several important questions have emerged from this review that warrant further 753 
investigation. A primary issue relates to the threshold (i.e., dose, period of exposure) that 754 
defines whether oxidative stress and inflammation are beneficial for or harmful to muscle 755 
adaptations to exercise. This threshold would be difficult to titrate because it most likely 756 
depends on the basal state of oxidative stress and inflammation at the start of exercise. In 757 
turn, this basal state may depend on periodization of training and recovery, together with 758 
age, health status, and diet. In addition, it is unclear whether undertaking different 759 
strategies simultaneously enhances or attenuates exercise-induced hormesis and which 760 
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combination of strategies might offer complementary or additive benefits. As highlighted in 761 
our review, some interventions such as NSAIDs and antioxidants exert different effects in 762 
young compared with older individuals and in trained compared with untrained individuals. 763 
Finally, the efficacy of a given intervention may depend on the capacity to ‘periodize’ such 764 
interventions during different phases of a training program. For example, during training to 765 
promote muscle hypertrophy and strength, interventions such as cryotherapy and the use 766 
of NSAIDs may dampen rather than enhance adaptation. However, during periods of regular 767 
competition when recovery is a priority, these strategies may be appropriate to alleviate 768 
muscle soreness and restrict secondary tissue injury.  769 
In conclusion, exercise-induced adaptations in skeletal muscle are regulated through 770 
interactions between various mechanical, metabolic, and physiological stressors and 771 
complex cellular machinery. Undoubtedly, a large body of work is still required to provide 772 
greater clarity on the appropriate uses and applications of strategies to modify skeletal 773 
muscle phenotypes. Exercise-induced hormesis is an intriguing notion that awaits further 774 
exploration. To adapt a phrase from a well-known bard, to intervene or not intervene: that 775 
remains the question. 776 
  777 
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Tables 1502 
Table 1. Effects of glycogen concentration on physiological responses to exercise 
in human skeletal muscle. 
Reference Design Δ% Low glycogen Findings 
(242) Acute 
−82% 163 mmol·kg–
1·dw  
↑AMPK acƟvity
(9) Acute 
−75% 103 mmol·kg–
1·dw 
↑p53 phosphorylaƟon 
↑Mitochondrial mRNA 
(172) Acute −65% 166 mmol·kg–
1·dw 
↑Mitochondrial mRNA 
(13) Acute −47% 167 mmol·kg–
1·dw 
↑Protein degradaƟon 
(72) Acute 
−30% 290 mmol·kg–
1·dw 
↑Leucine oxidaƟon 
↓Net protein balance 
(23) Acute −52% 180 mmol·kg–
1·dw 
↔ Muscle protein 
synthesis 
(255) Acute −69% 167 mmol·kg–
1·dw 
↓SR Ca2+ release rate 
(50) Acute 
−68% 245 mmol·kg–
1·dw 
↓ SR Ca2+ release rate 
(65) Chronic 
−68% 210 mmol·kg–1 ↑Mitochondrial enzyme 
activity 
(250) Chronic  −50% 250 µmol·g–1·dw ↑Mitochondrial enzymes 
↑Fat oxidaƟon 
dw, dry weight; SR, sarcoplasmic reticulum.
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Table 2. Summary of studies investigating the effects of heat stress on muscle regeneration.
Reference Study type Treatment Assessment 
period 
Outcome variables
(48) Rats; 
ischemia 
Hot water @ 42.5°C 
Duration: 20 min 
Timing: 12 h 
preinjury 
1.5 h postinjury Electron microscopy, 
PCr, ATP, HSP72 
(199) Rats; 
downhill 
running 
Heat chamber at 
42°C 
Duration: 60 min  
Timing: 48 h 
preinjury 
1, 2, 3, and 7 d 
postinjury 
ROS production and 
scavenging, HSP72, 
histology 
(223) Rats; 
downhill 
running 
Hot water @ 43°C;  
Duration: 20 min  
Timing: 48 h 
preinjury 
2 h and 2 d 
postinjury 
Histology, Akt, 
p70S6K, 
ERK1/2, JNK, HSP72, 
HSP25, MHC 
(96) Rats; 
cardiotoxin 
injury 
Heat chamber at 
41°C 
Duration: 60 min  
Timing: 24 h 
preinjury or 0 h 
postinjury 
1, 3, 7, 14, and 
28 d postinjury 
Muscle mass, 
central nucleated 
fibers, 
fiber CSA, HSP72, 
Pax7 
(25) Rats; acute 
strain 
injury 
Infrared lamp 
Duration: 5 min 
Timing: 30 min and 
2×/day postinjury 
1, 5, 10, and 15 d 
postinjury 
Lipid peroxidation, 
antioxidant enzymes 
myeloperoxidase 
(154) Rats; 
cardiotoxin 
injury 
Hot water @ 42°C 
Duration: 30 min  
Timing: 48 h 
postinjury and then 
every second day 
7 and 15 d 
postinjury 
Fiber CSA, myonuclei, 
Pax7, M-Cadherin, 
MyoD, HSP72, 
calcineurin 
(71) Rats; 
tenotomy 
Heat chamber @ 
40.5−41°C 
Duration: 30 min 
Timing: 24 h 
preinjury; 1−6 d 
postinjury 
7 d postinjury Muscle mass, 
histology, fiber CSA, 
HSP72, collagen, TGF-
β1, MMP-2, MMP-9, 
TIMP 
(216) Rats; acute 
crush 
injury 
Hot pack @ 42°C 
Duration: 20 min 
Timing: 5 min 
postinjury 
6 and 12 h; 1−7, 
14, and 28 d 
postinjury 
Central nucleated 
fibers 
Fiber CSA, 
macrophages 
TGF-β1, IGF-1, Pax7, 
collagen 
(68) Rats; acute 
crush 
injury 
Hot pack @ 42°C;  
Duration: 20 min 
Timing: 5 min 
postinjury 
12 h; 1−5, 7, 14, 
and 28 d 
postinjury 
MyoD, myogenin, 
PCNA 
Pax7 
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(217) Mice; 
acute 
treadmill 
running 
Heat chamber @ 
41°C 
Duration: 30 min 
Timing: Immediately 
postexercise 
30 min 
postexercise 
AMPK, ACC, p38 
MAPK, CaMKII, Akt, 
mTOR 
p70S6K 
Abbreviations: PCr, phosphocreatine; MHC, myosin heavy chain; PCNA, proliferating cells 
nuclear antigen; ROS, reactive oxygen species; CaMK, calmodulin-dependent protein kinase; 
CSA, cross-sectional area; Akt, protein kinase B; MMP, matrix metalloproteinase; TIMP, 
tissue inhibitor of matrix metalloproteinase. See Figure 1 for details of other abbreviations. 
1505 
56 
 
  1506 
 1507 
Table 3. Studies investigating the effects of cryotherapy on muscle regeneration. 
Reference Study 
type 
Treatment Assessment 
period 
Outcome variables 
(214) Rat; 
acute 
crush 
injury 
Topical icing 
Duration: 20 min 
duration 
Timing: 5 min 
postinjury  
6 and 12 h; 
1−7, 14, 
and 28 d 
postinjury 
Central nucleated fibers 
Fiber CSA, macrophage , 
TGF-β1, IGF-1, Pax7, 
collagen 
(25) Rat; 
acute 
crush 
injury 
Topical icing 
Duration: 5 min 
Timing: 30 min and 
2×/d postinjury 
1, 5, 10, 
and 15 d 
postinjury 
Lipid peroxidation 
Antioxidant enzymes 
Myeloperoxidase 
(174) Rat; 
acute 
contusion 
injury 
Topical icing
Duration: 5 min 
Timing: Immediately 
and 6 h postinjury 
1 d 
postinjury 
Lipid peroxidation 
Antioxidant enzymes 
Myeloperoxidase 
Na+-K+ ATPase, Ca2+ ATPase 
Lactate dehydrogenase
(76) Rat; 
acute 
contusion 
injury 
Topical icing 
Duration: 5 min; 
intermittently for 1 h  
Timing: Immediately 
postinjury or 24 h 
postinjury  
1, 2, and 6 
h; 1, 2, 5, 
and 7 d 
postinjury 
Neutrophil infiltration 
Macrophage infiltration 
Desmin+ myoblasts 
(102) Rat; 
acute 
contusion 
injury 
Cold saline (3°C) 
infusion 
Duration: 10 min 
Timing: 5 min 
postinjury 
15 min 
postinjury 
Leukocyte rolling and 
adhesion 
(189) Rat; 
acute 
contusion 
injury 
Cold saline (8°C) 
infusion 
Duration: 20 min 
Timing: ∼20 min 
postinjury 
1 h 
postinjury 
Edema, microvascular 
perfusion, leukocyte 
rolling/adhesion 
Neutrophils and 
macrophages  
(188) Rat; 
acute 
contusion 
injury 
Cold saline (8°C) 
infusion 
Duration: 6 h 
Timing: ∼20 min 
postinjury 
1 d 
postinjury 
Edema, microvascular 
perfusion, leukocyte 
rolling/adhesion 
Neutrophils and 
macrophages 
Desmin expression 
CSA, cross-sectional area; TGF, transforming growth factor 
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Table 4. Summary of physiological and molecular responses, acute and chronic adaptations to treatments that enhance or dampen exercise-
induced hormesis in skeletal muscle. 
 Treatments that dampen hormesis Treatments that enhance hormesis 
 Cryotherapy NSAIDs Antioxidant 
supplementation
Carbohydrate 
restriction 
Heat stress Blood flow 
restriction
Physiological 
rationale 
Analgesia 
↓ Muscle blood 
flow 
↓ Inflammation 
↑ Hydrostatic 
pressure 
Analgesia 
↓ Inflammation 
 
↓ Oxidative stress ↑ Metabolic 
stress 
↓ Muscle breakdown ↑ Metabolic 
stress 
↑ Oxidative 
stress 
↑ Blood 
pooling 
Cells and 
signalling 
molecules 
upregulated 
TGF-β IL-6 
MCP-1 
Cyclooxygenase 2
 AMPK 
ACC 
p53 
PGC-1α 
CS
SDH 
HAD 
COXIV 
PDK4 
Macrophages
HSPs 
MyoD 
Myogenin 
mTOR 
CS 
PGC-1α 
p38 MAPK 
p70S6K 
Pax7 
AMPK 
MAPK 
HSPs 
Cells and 
signalling 
molecules 
downregulated 
Neutrophils 
Macrophages 
IGF-1 
Pax7 
Prostaglandins 
ERK/RSK/MNK 
p70S6K/rpS6 
Leukotrienes 
Resolving 
mediators 
p38 MAPK 
ERK 
AMPK 
IL-6 
NFκB 
PGC-1α
Tfam 
COX 
SOD 
 Macrophages 
NFκB 
AMPK 
ACC 
 
Acute effects ↓ Soreness Sorness? 
↔ Inflammation 
↓ Protein 
synthesis 
↓ Satellite cells 
 ↓ SR Ca2+ release 
rate 
↑ Protein 
breakdown 
↓ Loss of strength* 
↓ Soreness* 
↓ Swelling 
↑ Range of motion* 
↑ Loss of 
strength 
↑ Soreness 
↑ Swelling 
Chronic effects ↓ Fibre CSA 
↑ Fibrosis 
↓ Strength 
Young healthy
  ↔ muscle 
mass? 
↓ Antioxidant 
enzymes 
↑ Mitochondrial 
enzymes 
↑ Fat oxidation 
↑ Mitochondrial enzymes 
↑ Respiratory chain protein 
content 
↑ 
Hypertrophy 
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  ↔ strength? 
Elderly 
  ↑ muscle mass 
  ↑ strength
↔ Performance 
Abbreviations: TGF, transforming growth factor; MCP, monocyte chemotactic protein; AMPK, adenosine monophosphate activated protein 
kinase; ACC, acetyl-CoA-carboxylase; PGC, peroxisome proliferator-activated receptor coactivator; CS, citrate synthase; SDH, succinate 
dehydrogenase; HAD, hydroxyacyl-CoA-dehydrogenase; COX, cytochrome oxidase; PDK, pyruvate dehydrogenase kinase; HSP, heat shock 
protein; Pax, paired box protein; mTOR; mammalian target of rapamycin; Mnk, MAPK-interacting kinase; RSK, p90 ribosomal S6 kinase; rpS6, 
ribosomal S6 kinase; Tfam, mitochondrial transcription factor A; SOD, superoxide dismutase; CSA, cross-sectional area. ↔ no change. * 
conflicting evidence for an increase/decrease or no change. 
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